Skip to Main content
Number of documents

109

Mr Pascal Finetti


Journal articles109 documents

  • Alexia Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, et al.. Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers, MDPI, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩. ⟨hal-03637735⟩
  • Chaïma Cherif, Dang Tan Nguyen, Clément Paris, Thi Khanh Le, Thibaud Sefiane, et al.. Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity. Oncogene, Nature Publishing Group, 2022, 41 (1), pp.125-137. ⟨10.1038/s41388-021-02039-2⟩. ⟨hal-03599176⟩
  • Francois Bertucci, Vincent Niziers, Alexandre de Nonneville, Pascal Finetti, Léna Mescam, et al.. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Journal for Immunotherapy of Cancer, BMJ Publishing Group 2022, 10 (1), pp.e003687. ⟨10.1136/jitc-2021-003687⟩. ⟨hal-03583256⟩
  • Alexandre de Nonneville, Pascal Finetti, Emilie Mamessier, François Bertucci. RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2022, ⟨10.1093/jnci/djac031⟩. ⟨hal-03583244⟩
  • Charlotte Rypens, F. Bertucci, Pascal Finetti, Fredika Robertson, Sandra Fernandez, et al.. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. npj Breast Cancer, Nature, 2022, 8 (1), pp.12. ⟨10.1038/s41523-021-00379-6⟩. ⟨hal-03623626⟩
  • Alexia Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, et al.. Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients. Cancers, MDPI, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩. ⟨hal-03583233⟩
  • David Birnbaum, Sebastian K.S. Begg, Pascal Finetti, Charles Vanderburg, Anupriya Kulkarni, et al.. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research, American Association for Cancer Research, 2021, 27 (8), pp.2314-2325. ⟨10.1158/1078-0432.CCR-20-1039⟩. ⟨hal-03623108⟩
  • Gayathri Devi, Pascal Finetti, Michael Morse, Seayoung Lee, Alexandre de Nonneville, et al.. Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. Cancers, MDPI, 2021, 13 (11), pp.2807. ⟨10.3390/cancers13112807⟩. ⟨hal-03623076⟩
  • François Bertucci, Laurys Boudin, Pascal Finetti, Christophe van Berckelaer, Peter van Dam, et al.. Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. OncoImmunology, Taylor & Francis, 2021, 10 (1), ⟨10.1080/2162402X.2021.1929724⟩. ⟨hal-03583271⟩
  • François Bertucci, Anthony Gonçalves, Arnaud Guille, José Adelaïde, Séverine Garnier, et al.. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial. Genome Medicine, BioMed Central, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩. ⟨hal-03583277⟩
  • Yuchen Guo, Monica Gabola, Rossano Lattanzio, Conception Paul, Valérie Pinet, et al.. Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer. Journal of Clinical Investigation, American Society for Clinical Investigation, 2021, 131 (4), ⟨10.1172/JCI131517⟩. ⟨hal-03152320⟩
  • Angélina Acier, Magali Godard, Fanny Gassiot, Pascal Finetti, Marion Rubis, et al.. LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma.. Communications Biology, Nature Publishing Group, 2021, 4 (1), pp.987. ⟨10.1038/s42003-021-02508-0⟩. ⟨hal-03452855⟩
  • Alexandre Nonneville, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier, François Bertucci. WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer. Advanced Science, Wiley Open Access, 2021, 8 (17), pp.2101030. ⟨10.1002/advs.202101030⟩. ⟨hal-03583269⟩
  • Racha Fayad, Monserrat Rojas, Mariagrazia Partisani, Pascal Finetti, Shiraz Dib, et al.. EFA6B regulates a stop signal for collective invasion in breast cancer. Nature Communications, Nature Publishing Group, 2021, 12, pp.2198. ⟨10.1038/s41467-021-22522-4⟩. ⟨hal-03434635⟩
  • Evodie Peperstraete, Clément Lecerf, Jordan Collette, Constance Vennin, Ludivine Raby, et al.. Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions. Cancers, MDPI, 2020, 12 (7), pp.1730. ⟨10.3390/cancers12071730⟩. ⟨hal-02896573⟩
  • Bérengère Dadone-Montaudié, Audrey Laroche-Clary, Aline Mongis, Emmanuel Chamorey, Ilaria Di Mauro, et al.. Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting. Cancers, MDPI, 2020, 12, ⟨10.3390/cancers12103058⟩. ⟨hal-03034592⟩
  • Anaïs Aulas, Pascal Finetti, Shawn Lyons, François Bertucci, Daniel Birnbaum, et al.. Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?. Cancers, MDPI, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩. ⟨hal-02958029⟩
  • Mabrouka Doghman-Bouguerra, Pascal Finetti, Nelly Durand, Ivy Zortéa Parise, Silviu Sbiera, et al.. Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC. Cancers, MDPI, 2020, 12, ⟨10.3390/cancers12030689⟩. ⟨inserm-02508381⟩
  • Anaïs Aulas, Pascal Finetti, Shawn Lyons, François Bertucci, Daniel Birnbaum, et al.. Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?. Cancers, MDPI, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩. ⟨hal-03606494⟩
  • Kim Honselmann, Pascal Finetti, David Birnbaum, Christian Monsalve, Ulrich Wellner, et al.. Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Molecular Cancer Research, American Association for Cancer Research, 2020, 18 (12), pp.1889-1902. ⟨10.1158/1541-7786.mcr-20-0439⟩. ⟨hal-03623660⟩
  • François Bertucci, Pascal Finetti, Anthony Goncalves, Daniel Birnbaum. The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype. npj Breast Cancer, Nature, 2020, 6 (1), pp.8. ⟨10.1038/s41523-020-0151-5⟩. ⟨hal-03623676⟩
  • Pascal Finetti, I. Zawati, O. Adouni, Ma. Manai, A. Gamoudi, et al.. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study. Cancer Radiothérapie, Elsevier Masson, 2020, 24 (3), pp.206-214. ⟨10.1016/j.canrad.2020.01.004⟩. ⟨hal-03637780⟩
  • Marguerite Tyran, Nadine Carbuccia, Séverine Garnier, Arnaud Guille, José Adelaïde, et al.. A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases. Cancers, MDPI, 2019, 11 (5), pp.665. ⟨10.3390/cancers11050665⟩. ⟨hal-02533361⟩
  • Shuichi Aoki, Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, et al.. Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors. Cancers, MDPI, 2019, 11 (4), pp.497. ⟨10.3390/cancers11040497⟩. ⟨hal-03583447⟩
  • Francois Bertucci, Pascal Finetti, Audrey Monneur, Delphine Perrot, Christine Chevreau, et al.. PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target. Molecular Oncology, Elsevier, 2019, 13 (7), pp.1577-1588. ⟨10.1002/1878-0261.12522⟩. ⟨hal-02504850⟩
  • Alexandre de Nonneville, Pascal Finetti, José Adelaïde, Eric Lambaudie, Patrice Viens, et al.. A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. Cancers, MDPI, 2019, 11 (8), pp.1158. ⟨10.3390/cancers11081158⟩. ⟨hal-02518929⟩
  • Luc Camoin, Jean-Paul Borg, Avais Daulat, Pascal Finetti, Diego Revinski, et al.. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer. British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩. ⟨hal-02145896⟩
  • Avais Daulat, Pascal Finetti, Diego Revinski, Mônica Silveira Wagner, Luc Camoin, et al.. ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer. British Journal of Cancer, Cancer Research UK, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩. ⟨hal-02518543⟩
  • Emilien Billon, Pascal Finetti, Alexandre Bertucci, Patricia Niccoli, Daniel Birnbaum, et al.. PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma. OncoImmunology, Taylor & Francis, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩. ⟨hal-02509464⟩
  • David Jérémie Birnbaum, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier, Francois Bertucci. XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma. Journal of Clinical Medicine, MDPI, 2019, 8 (5), pp.596. ⟨10.3390/jcm8050596⟩. ⟨hal-02509509⟩
  • Alexia Lopresti, Fabrice Malergue, François Bertucci, Maria Lucia Liberatoscioli, Séverine Garnier, et al.. Sensitive and easy screening for circulating tumor cells by flow cytometry. JCI Insight, American Society for Clinical Investigation, 2019, 4 (14), ⟨10.1172/jci.insight.128180⟩. ⟨hal-02529764⟩
  • Emilien Billon, Pascal Finetti, Alexandre Bertucci, Patricia Niccoli, Daniel Birnbaum, et al.. PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma. OncoImmunology, Taylor & Francis, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩. ⟨hal-03606482⟩
  • Abir Arfaoui, Claire Rioualen, Violette Azzoni, Guillaume Pinna, Pascal Finetti, et al.. A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells. EMBO Molecular Medicine, Wiley Open Access, 2019, 11 (10), pp.e9930. ⟨10.15252/emmm.201809930⟩. ⟨hal-02539524⟩
  • Romain Lévêque, Cyril Corbet, Léo Aubert, Matthieu Guilbert, Chann Lagadec, et al.. ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2. Cancer Letters, Elsevier, 2019, 449, pp.196-206. ⟨10.1016/j.canlet.2019.02.019⟩. ⟨hal-02529705⟩
  • Sylvain Garciaz, Lia N’guyen Dasi, Pascal Finetti, Christine Chevalier, Julien Vernerey, et al.. Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation. Clinical Epigenetics, BioMed Central, 2019, 11 (1), ⟨10.1186/s13148-019-0738-6⟩. ⟨hal-02322283⟩
  • Mathilde Guérin, Anthony Gonçalves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, et al.. Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer. Oncotarget, Impact journals, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩. ⟨hal-02145636⟩
  • Raoudha Doghri, Maroua Manai, Pascal Finetti, Maha Driss, Emilie Agavnian, et al.. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value. International Journal of Molecular Sciences, MDPI, 2018, 19 (1), ⟨10.3390/ijms19010041⟩. ⟨hal-02143620⟩
  • Maroua Manai, Pascal Finetti, Nesrine Mejri, Salma Athimni, Daniel Birnbaum, et al.. Inflammatory breast cancer in 210�patients: A retrospective study on epidemiological, anatomo‑clinical features and therapeutic results. Molecular and Clinical Oncology, Spandidos Publications, 2018, 10 (2), pp.223-230. ⟨10.3892/mco.2018.1773⟩. ⟨hal-02530356⟩
  • Francois Bertucci, Pascal Finetti, Ines Simeone, Wouter Hendrickx, Ena Wang, et al.. The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer. Breast Cancer Research and Treatment, Springer Verlag, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩. ⟨hal-02143596⟩
  • Francois Bertucci, Pascal Finetti, Alexandre de Nonneville, Daniel Birnbaum. ``Wnt/beta-Catenin in GIST''-Letter. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (1), pp.327-328. ⟨10.1158/1535-7163.MCT-17-0948⟩. ⟨hal-02143618⟩
  • Leonor Lopez Almeida, Michael Sebbagh, Francois Bertucci, Pascal Finetti, Julien Wicinski, et al.. The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/beta-Catenin Signaling. Stem Cell Reports, Elsevier, 2018, 11 (5), pp.1040-1050. ⟨10.1016/j.stemcr.2018.09.008⟩. ⟨hal-02143631⟩
  • David Birnbaum, François Bertucci, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Elsevier, 2018, 1869 (2), pp.248-255. ⟨10.1016/j.bbcan.2018.02.001⟩. ⟨hal-03583468⟩
  • Alexandre de Nonneville, François Bertucci, Pascal Finetti, D. Perrot, M. Nilbert, et al.. Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care. BMC Palliative Care, BioMed Central, 2018, 17 (1), pp.104. ⟨10.1186/s12904-018-0357-6⟩. ⟨hal-03583406⟩
  • François Bertucci, Pascal Finetti, Ines Simeone, Wouter Hendrickx, Ena Wang, et al.. The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer. British Journal of Cancer, Cancer Research UK, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩. ⟨hal-03606514⟩
  • Emilie Mamessier, David Birnbaum, Pascal Finetti, Daniel Birnbaum, François Bertucci. CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors. Annals of translational medicine, AME Publishing Company, 2018, 6 (3), pp.54 - 54. ⟨10.21037/atm.2017.11.26⟩. ⟨hal-01765411⟩
  • Maroua Manai, Jeanne Thomassin-Piana, Amor Gamoudi, Pascal Finetti, Marc Lopez, et al.. MARCKS protein overexpression in inflammatory breast cancer. Oncotarget, Impact journals, 2017, 8, pp.6246 - 6257. ⟨10.18632/oncotarget.14057⟩. ⟨hal-01787705⟩
  • Anne Morel, Christophe Ginestier, Roxane Pommier, Olivier Cabaud, Emmanuelle Ruiz, et al.. A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nature Medicine, Nature Publishing Group, 2017, 23 (5), pp.568 - 578. ⟨10.1038/nm.4323⟩. ⟨hal-01788395⟩
  • David Birnbaum, Pascal Finetti, Alexia Lopresti, Marine Gilabert, Flora Poizat, et al.. A 25-gene classifier predicts overall survival in resectable pancreatic cancer. BMC Medicine, BioMed Central, 2017, 15 (1), ⟨10.1186/s12916-017-0936-z⟩. ⟨hal-01787872⟩
  • Ruth Rodriguez-Barrueco, Erin Nekritz, François Bertucci, Jiyang Yu, Felix Sanchez-Garcia, et al.. miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy. Genes and Development, Cold Spring Harbor Laboratory Press, 2017, 31 (6), pp.553-566. ⟨10.1101/gad.292318.116⟩. ⟨hal-01787959⟩
  • François Bertucci, Pascal Finetti, Daniel Birnbaum. Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas—Letter. Molecular Cancer Therapeutics, American Association for Cancer Research, 2017, 16 (10), pp.2324 - 2324. ⟨10.1158/1535-7163.MCT-17-0491⟩. ⟨hal-01787271⟩
  • Audrey Monneur, Anthony Gonçalves, Marine Gilabert, Pascal Finetti, Carole Tarpin, et al.. Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers. Oncotarget, Impact journals, 2017, 8 (39), pp.66019 - 66032. ⟨10.18632/oncotarget.19732⟩. ⟨inserm-01984755⟩
  • Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, François Bertucci, et al.. Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis. OncoImmunology, Taylor & Francis, 2017, 6 (2), ⟨10.1080/2162402X.2016.1253654⟩. ⟨hal-01788951⟩
  • Rita El Helou, Guillaume Pinna, Olivier Cabaud, Julien Wicinski, Ricky Bhajun, et al.. miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling. Cell Reports, Elsevier Inc, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩. ⟨hal-01789620⟩
  • Madhura Joglekar-Javadekar, Steven van Laere, Michael Bourne, Manal Moalwi, Pascal Finetti, et al.. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia, Elsevier, 2017, 19 (7), pp.564-573. ⟨10.1016/j.neo.2017.03.002⟩. ⟨hal-01789694⟩
  • François Bertucci, Pascal Finetti, Delphine Perrot, Agnès Leroux, Françoise Collin, et al.. PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas. OncoImmunology, Taylor & Francis, 2017, 6 (3), pp.e1278100. ⟨10.1080/2162402X.2016.1278100⟩. ⟨hal-01765418⟩
  • François Bertucci, David Birnbaum, Pascal Finetti, Marine Gilabert, Flora Poizat, et al.. Prognostic Value of Molecular Subtypes in Pancreatic Cancer. Pancreas, 2017, 46 (4), pp.e29-e31. ⟨10.1097/MPA.0000000000000787⟩. ⟨hal-03606452⟩
  • David Birnbaum, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier, François Bertucci. Validation and comparison of the molecular classifications of pancreatic carcinomas. Molecular Cancer, BioMed Central, 2017, 16 (1), pp.168. ⟨10.1186/s12943-017-0739-z⟩. ⟨hal-03583469⟩
  • Chris Planque, Fatemeh Rajabi, Fanny Grillet, Pascal Finetti, François Bertucci, et al.. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse. Oncotarget, Impact journals, 2016, 7 (35), pp.56558-56573. ⟨10.18632/oncotarget.10646⟩. ⟨hal-01431926⟩
  • Julie Giraud, Laura Failla, Jean-Marc Pascussi, Ebba Louise Lagerqvist, Jérémy Ollier, et al.. Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells. Cancer Research, American Association for Cancer Research, 2016, 76 (12), pp.3618 - 3628. ⟨10.1158/0008-5472.CAN-15-1497⟩. ⟨hal-01905320⟩
  • David Birnbaum, François Bertucci, Pascal Finetti, José Adélaïde, Marc Giovannini, et al.. Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.. Cancer Genomics and Proteomics, International Institute of Anticancer Research, 2016, 13 (3), pp.191-200. ⟨hal-03583479⟩
  • David Birnbaum, Pascal Finetti, Alexia Lopresti, Marine Gilabert, Flora Poizat, et al.. Prognostic value of PDL1 expression in pancreatic cancer. Oncotarget, Impact journals, 2016, 7 (44), ⟨10.18632/oncotarget.11685⟩. ⟨hal-01765421⟩
  • Avais M Daulat, François Bertucci, Stéphane Audebert, Arnauld Sergé, Pascal Finetti, et al.. PRICKLE1 contributes to cancer cell dissemination through its interaction with mTORC2 . Developmental Cell, Elsevier, 2016, pp.311-325. ⟨10.1016/j.devcel.2016.04.011⟩. ⟨hal-01321061⟩
  • David Birnbaum, Pascal Finetti, Alexia Lopresti, Marine Gilabert, Flora Poizat, et al.. Prognostic value of PDL1 expression in pancreatic cancer. Oncotarget, Impact journals, 2016, 7 (44), pp.71198-71210. ⟨10.18632/oncotarget.11685⟩. ⟨hal-03583475⟩
  • Tania M. Puvirajesinghe, François Bertucci, Ashish Jain, Pierluigi Scerbo, Edwige Belotti, et al.. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer. Nature Communications, Nature Publishing Group, 2016, 7, pp.10318. ⟨10.1038/ncomms10318⟩. ⟨hal-01447570⟩
  • Renaud Sabatier, Pascal Finetti, Emilie Mamessier, José Adelaide, Max Chaffanet, et al.. Prognostic and predictive value of PDL1 expression in breast cancer. Oncotarget, Impact journals, 2015, 6 (7), pp.5449-5464. ⟨10.18632/oncotarget.3216⟩. ⟨hal-03583484⟩
  • Christophe Zemmour, Francois Bertucci, Pascal Finetti, Bernard Chetrit, Daniel Birnbaum, et al.. Prediction of Early Breast Cancer Metastasis from DNA Microarray Data Using High-Dimensional Cox Regression Models. Cancer Informatics, Libertas Academica, 2015, 14(Suppl 2), pp.129-138. ⟨10.4137/cin.s17284⟩. ⟨inserm-01996812⟩
  • Andrea Remo, Ines Simeone, Massimo Pancione, Pietro Parcesepe, Pascal Finetti, et al.. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer. Journal of Translational Medicine, BioMed Central, 2015, 13 (1), pp.138. ⟨10.1186/s12967-015-0492-2⟩. ⟨inserm-01264508⟩
  • Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, Laura Saucedo-Cuevas, Patricia Villagrasa, et al.. HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers. Breast Cancer Research, BioMed Central, 2015, 17 (1), pp.149. ⟨10.1186/s13058-015-0658-0⟩. ⟨inserm-01254136⟩
  • Constance Vennin, Nathalie Spruyt, Fatima Dahmani, Sylvain Julien, François Bertucci, et al.. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget, Impact journals, 2015, 6 (30), ⟨10.18632/oncotarget.4976⟩. ⟨hal-02347866⟩
  • François Bertucci, Pascal Finetti, Emilie Mamessier, Maria Abbondanza Pantaleo, Annalisa Astolfi, et al.. PDL1 expression is an independent prognostic factor in localized GIST. OncoImmunology, Taylor & Francis, 2015, 4 (5), pp.e1002729. ⟨10.1080/2162402X.2014.1002729⟩. ⟨hal-03583480⟩
  • François Bertucci, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier. The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers. OncoImmunology, Taylor & Francis, 2015, 5 (3), pp.e1085148. ⟨10.1080/2162402X.2015.1085148⟩. ⟨hal-03583477⟩
  • François Bertucci, Pascal Finetti, Cécile Colpaert, Emilie Mamessier, Maxime Parizel, et al.. PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy. Oncotarget, Impact journals, 2015, 6 (15), pp.13506-13519. ⟨10.18632/oncotarget.3642⟩. ⟨hal-03583483⟩
  • Maria Katsogiannou, Claudia Andrieu, Virginie Baylot, Anaïs Baudot, Nelson J Dusetti, et al.. The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.. Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2014, pp.3585-601. ⟨10.1074/mcp.M114.041228⟩. ⟨hal-01104661⟩
  • Rita El Helou, Julien Wicinski, Arnaud Guille, José Adelaïde, Pascal Finetti, et al.. Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome. STEM CELLS, AlphaMed Press, 2014, 32 (11), pp.3031-3036. ⟨10.1002/stem.1792⟩. ⟨hal-01431934⟩
  • Renaud Sabatier, Pascal Finetti, Arnaud Guille, José Adelaïde, Max Chaffanet, et al.. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization. Molecular Cancer, BioMed Central, 2014, 13, pp.228. ⟨10.2174/156652412798376134⟩. ⟨inserm-01192813⟩
  • Stéphanie Cornen, Arnaud Guille, José Adelaïde, Lynda Addou-Klouche, Pascal Finetti, et al.. Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling. PLoS ONE, Public Library of Science, 2014, 9 (1), pp.e81843. ⟨10.1371/journal.pone.0081843⟩. ⟨hal-01614950⟩
  • Marine Gilabert, Simon Launay, Christophe Ginestier, François Bertucci, Stéphane Audebert, et al.. Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib. PLoS ONE, Public Library of Science, 2014, 9 (8), pp.e104302. ⟨10.1371/journal.pone.0104302⟩. ⟨hal-01431935⟩
  • Pascal Finetti, A Chaix, M-L Arcangeli, S Lopez, E Voisset, et al.. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570. Oncogene, Nature Publishing Group, 2014, 33 (7), pp.872-881. ⟨10.1038/onc.2013.12⟩. ⟨hal-03637783⟩
  • Emmanuelle Charafe-Jauffret, Christophe Ginestier, François Bertucci, Olivier Cabaud, Julien Wicinski, et al.. ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program. Cancer Research, American Association for Cancer Research, 2013, 73 (24), pp.7290-7300. ⟨10.1158/0008-5472.CAN-12-4704⟩. ⟨hal-01431937⟩
  • Marion A. Salvador, Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, et al.. The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression. Clinical Cancer Research, American Association for Cancer Research, 2013, 19 (23), pp.6520-6531. ⟨10.1158/1078-0432.CCR-13-0877⟩. ⟨hal-01431936⟩
  • Olivier Stahl, Hugo Duvergey, Arnaud Guille, Fanny Blondin, Alexandre Vecchio, et al.. Djeen (Database for Joomla!'s Extensible Engine): A Research Information Management System for flexible multi-technology project administration.. BMC Research Notes, BioMed Central, 2013, 6 (1), pp.223. ⟨10.1186/1756-0500-6-223⟩. ⟨inserm-00832573⟩
  • Corinne Bouvier, François Bertucci, Philippe Métellus, Pascal Finetti, André de Paula, et al.. ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2013, 1 (1), pp.10. ⟨inserm-00837790⟩
  • François Bertucci, Corinne Bouvier-Labit, Pascal Finetti, Philippe Metellus, José Adelaïde, et al.. Gene Expression Profiling of Solitary Fibrous Tumors. PLoS ONE, Public Library of Science, 2013, 8 (5), pp.e64497. ⟨10.1371/journal.pone.0064497⟩. ⟨hal-01537869⟩
  • F Bertucci, Pascal Finetti, J Ostrowski, W Kim, H Kim, et al.. Genomic Grade Index predicts postoperative clinical outcome of GIST. British Journal of Cancer, Cancer Research UK, 2012, 107 (8), pp.1433-1441. ⟨10.1038/bjc.2012.390⟩. ⟨hal-03637782⟩
  • Maxime Garcia, Raphaelle Millat-Carus, François Bertucci, Pascal Finetti, Daniel Birnbaum, et al.. Interactome-Transcriptome integration for predicting distant metastasis in breast cancer. Bioinformatics, Oxford University Press (OUP), 2012, 28 (5), pp.672-678. ⟨10.1093/bioinformatics/bts025⟩. ⟨hal-01784470⟩
  • Juliette Thariat, René-Jean Bensadoun, Marie-Christine Etienne-Grimaldi, Dominique Grall, Frédérique Penault-Llorca, et al.. Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02).. Clinical Cancer Research, American Association for Cancer Research, 2012, 18 (18), pp.5123-33. ⟨10.1158/1078-0432.CCR-12-1518⟩. ⟨hal-00770510⟩
  • Christophe Ginestier, Florence Monville, Julien Wicinski, Olivier Cabaud, Nathalie Cervera, et al.. Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target. STEM CELLS, AlphaMed Press, 2012, 30 (7), pp.1327-1337. ⟨10.1002/stem.1122⟩. ⟨hal-01431941⟩
  • Michael Guedj, Laëtitia Marisa, Aurélien de Reynies, Béatrice Orsetti, Renaud Schiappa, et al.. A refined molecular taxonomy of breast cancer.: molecular classification of breast cancer. Oncogene, Nature Publishing Group, 2012, 31 (9), pp.1196-206. ⟨10.1038/onc.2011.301⟩. ⟨inserm-00611752⟩
  • David Birnbaum, José Adélaïde, Emilie Mamessier, Pascal Finetti, Arnaud Lagarde, et al.. Genome profiling of pancreatic adenocarcinoma. Genes, Chromosomes and Cancer, Wiley, 2011, 50 (6), pp.456-465. ⟨10.1002/gcc.20870⟩. ⟨hal-03583490⟩
  • Fabrice Sircoulomb, Nathalie Nicolas, Anthony Ferrari, Pascal Finetti, Ismahane Bekhouche, et al.. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer. EMBO Molecular Medicine, Wiley Open Access, 2011, 3 (3), pp.153-166. ⟨10.1002/emmm.201100121⟩. ⟨hal-01431945⟩
  • R Sabatier, Pascal Finetti, J Bonensea, J Jacquemier, J Adelaide, et al.. A seven-gene prognostic model for platinum-treated ovarian carcinomas. British Journal of Cancer, Cancer Research UK, 2011, 105 (2), pp.304-311. ⟨10.1038/bjc.2011.219⟩. ⟨hal-03637781⟩
  • Jocelyne Jacquemier, Jean-Marie Boher, Henri Roche, Benjamin Esterni, Daniel Serin, et al.. Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial.. Breast Cancer Research, BioMed Central, 2011, 13 (6), pp.R109. ⟨10.1186/bcr3051⟩. ⟨inserm-00647247⟩
  • Renaud Sabatier, Pascal Finetti, Emilie Mamessier, Stéphane Raynaud, Nathalie Cervera, et al.. Kinome expression profiling and prognosis of basal breast cancers. Molecular Cancer, BioMed Central, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩. ⟨hal-03606422⟩
  • Renaud Sabatier, Pascal Finetti, Emilie Mamessier, Stéphane Raynaud, Nathalie Cervera, et al.. Kinome expression profiling and prognosis of basal breast cancers.. Molecular Cancer, BioMed Central, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩. ⟨inserm-00614833⟩
  • Anthony Gonçalves, Pascal Finetti, Renaud Sabatier, Marine Gilabert, José Adelaïde, et al.. -- mRNA expression in human breast cancer: a meta-analysis. Breast Cancer Research and Treatment, Springer Verlag, 2010, 127 (1), pp.273-281. ⟨10.1007/s10549-010-1199-y⟩. ⟨hal-00594471⟩
  • Véronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, José Adelaïde, Nadine Carbuccia, et al.. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British Journal of Haematology, Wiley, 2010, 151 (4), pp.365. ⟨10.1111/j.1365-2141.2010.08381.x⟩. ⟨hal-00580698⟩
  • François Bertucci, Nathalie Borie, Henri Roche, Thomas Bachelot, Jean-Marc Doussal, et al.. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer. Breast Cancer Research and Treatment, Springer Verlag, 2010, 127 (2), pp.363-373. ⟨10.1007/s10549-010-1003-z⟩. ⟨hal-00594464⟩
  • Renaud Sabatier, Pascal Finetti, Nathalie Cervera, Eric Lambaudie, Benjamin Esterni, et al.. A gene expression signature identifies two prognostic subgroups of basal breast cancer: Multigene prognostic classification of basal breast cancers. Breast Cancer Research and Treatment, Springer Verlag, 2010, 126 (2), pp.407-420. ⟨10.1007/s10549-010-0897-9⟩. ⟨hal-00583558⟩
  • Christophe Ginestier, Julien Wicinski, Nathalie Cervera, Florence Monville, Pascal Finetti, et al.. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle, Taylor & Francis, 2009, 8 (20), pp.3297-3302. ⟨10.4161/cc.8.20.9761⟩. ⟨hal-01431955⟩
  • Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, et al.. Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature. Cancer Research, American Association for Cancer Research, 2009, 69 (4), pp.1302-1313. ⟨10.1158/0008-5472.CAN-08-2741⟩. ⟨hal-01431954⟩
  • François Bertucci, Béatrice Orsetti, Vincent Nègre, Pascal Finetti, Carole Rougé, et al.. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.. Oncogene, Nature Publishing Group, 2008, 27 (40), pp.5359-72. ⟨10.1038/onc.2008.158⟩. ⟨inserm-00290484⟩
  • Stephanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, Carole Berruyer-Pouyet, Christophe Ginestier, et al.. Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer, BioMed Central, 2007, 7, ⟨10.1186/1171-2407-7-73⟩. ⟨hal-01431961⟩
  • Emmanuelle Charafe-Jauffret, Florence Monville, Francois Bertucci', Benjamin Esterni, Christophe Ginestier, et al.. Moesin expression is a marker of basal breast carcinomas. International Journal of Cancer, Wiley, 2007, 121 (8), pp.1779-1785. ⟨10.1002/ijc.22923⟩. ⟨hal-01431969⟩
  • Anne Letessier, Fabrice Sircoulomb, Christophe Ginestier, Nathalie Cervera, Florence Monville, et al.. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.. BMC Cancer, BioMed Central, 2006, 6, pp.245. ⟨10.1186/1471-2407-6-245⟩. ⟨inserm-00122145⟩
  • Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Sverine Esteyries, Benjamin Esterni, et al.. Prognosis and gene expression profiling of 20q13-amplified breast cancers. Clinical Cancer Research, American Association for Cancer Research, 2006, 12 (15), pp.4533-4544. ⟨10.1158/1078-0432.CCR-05-2339⟩. ⟨hal-01431971⟩
  • H Lelièvre, N Cervera, Pascal Finetti, F Delhommeau, W Vainchenker, et al.. Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2006, 20 (10), pp.1885-1888. ⟨10.1038/sj.leu.2404361⟩. ⟨hal-03637785⟩
  • François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Emilie Mamessier, et al.. Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers. Cancer Research, American Association for Cancer Research, 2006, 66 (9), pp.4636-4644. ⟨10.1158/0008-5472.CAN-06-0031⟩. ⟨hal-03606415⟩
  • François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, José Adélaïde, et al.. Comparison of Induced Sputum and Bronchoalveolar Lavage in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation, Elsevier, 2006, 25 (5), pp.523-532. ⟨10.1016/j.healun.2005.12.009⟩. ⟨hal-03583497⟩
  • Véronique Gelsi-Boyer, Béatrice Orsetti, Nathalie Cervera, Pascal Finetti, Fabrice Sircoulomb, et al.. Comprehensive profiling of 8p11-12 amplification in breast cancer.. Molecular Cancer Research, American Association for Cancer Research, 2005, 3 (12), pp.655-67. ⟨10.1158/1541-7786.MCR-05-0128⟩. ⟨inserm-00158812⟩